Cargando…

Targeting ECM Disrupts Cancer Progression

Metastatic complications are responsible for more than 90% of cancer-related deaths. The progression from an isolated tumor to disseminated metastatic disease is a multistep process, with each step involving intricate cross talk between the cancer cells and their non-cellular surroundings, the extra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venning, Freja A., Wullkopf, Lena, Erler, Janine T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611145/ https://www.ncbi.nlm.nih.gov/pubmed/26539408 http://dx.doi.org/10.3389/fonc.2015.00224

Ejemplares similares

Deciphering the temporal heterogeneity of cancer-associated fibroblast subpopulations in breast cancer
por: Venning, Freja Albjerg, et al.
Publicado: (2021)

The Role of the ECM in Lung Cancer Dormancy and Outgrowth
por: Parker, Amelia L., et al.
Publicado: (2020)

A Complex and Evolutive Character: Two Face Aspects of ECM in Tumor Progression
por: Sala, Margaux, et al.
Publicado: (2020)

Cancer cells’ ability to mechanically adjust to extracellular matrix stiffness correlates with their invasive potential
por: Wullkopf, Lena, et al.
Publicado: (2018)

Dynamics of cancerous tissue correlates with invasiveness
por: West, Ann-Katrine Vransø, et al.
Publicado: (2017)

Hypoxic Signalling in Tumour Stroma
por: Laitala, Anu, et al.
Publicado: (2018)

Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer
por: Stewart, Delisha A, et al.
Publicado: (2004)

Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis
por: Madsen, Chris D, et al.
Publicado: (2015)

Obesity-Associated ECM Remodeling in Cancer Progression
por: Li, Junyan, et al.
Publicado: (2022)

Targeting p97 to Disrupt Protein Homeostasis in Cancer
por: Vekaria, Pratikkumar Harsukhbhai, et al.
Publicado: (2016)

A Novel TAF-Related Signature Based on ECM Remodeling Genes Predicts Glioma Prognosis
por: Wang, Lin-jian, et al.
Publicado: (2022)

FES null mice demonstrate a reduction in neutrophil dependent pancreatic cancer metastatic burden
por: Strøbech, Jan E., et al.
Publicado: (2023)

ECM signals ECM degradation
por: Powell, Kendall
Publicado: (2006)

The PDAC Extracellular Matrix: A Review of the ECM Protein Composition, Tumor Cell Interaction, and Therapeutic Strategies
por: Perez, Vincent M., et al.
Publicado: (2021)

ECM Depletion Is Required to Improve the Intratumoral Uptake of Iron Oxide Nanoparticles in Poorly Perfused Hepatocellular Carcinoma
por: Yeow, Yen Ling, et al.
Publicado: (2022)

Zinc Finger Protein CTCF Regulates Extracellular Matrix (ECM)-Related Gene Expression Associated With the Wnt Signaling Pathway in Gastric Cancer
por: Liu, Chenbin, et al.
Publicado: (2021)

Targeting sterol-O-acyltransferase 1 to disrupt cholesterol metabolism for cancer therapy
por: Tu, Teng, et al.
Publicado: (2023)

Targeting Oncogenic Wnt/β-Catenin Signaling in Adrenocortical Carcinoma Disrupts ECM Expression and Impairs Tumor Growth
por: Penny, Morgan K., et al.
Publicado: (2023)

Human colorectal cancer progression correlates with LOX-induced ECM stiffening
por: Wei, Bo, et al.
Publicado: (2017)

Syndecans as Modulators and Potential Pharmacological Targets in Cancer Progression
por: Barbouri, Despoina, et al.
Publicado: (2014)

Mutant p53 in Cancer Progression and Targeted Therapies
por: Zhu, Gaoyang, et al.
Publicado: (2020)

Circadian disruption and cancer- and treatment-related symptoms
por: Amidi, Ali, et al.
Publicado: (2022)

Proteomic Identification of a Gastric Tumor ECM Signature Associated With Cancer Progression
por: Moreira, Ana M., et al.
Publicado: (2022)

Long Non-coding RNA LINC01787 Drives Breast Cancer Progression via Disrupting miR-125b Generation
por: Li, Yongzhen, et al.
Publicado: (2019)

Tumor Angiocrine Signaling: Novel Targeting Opportunity in Cancer
por: Oria, Victor Oginga, et al.
Publicado: (2023)

Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression
por: Pandey, Swaroop Kumar, et al.
Publicado: (2022)

Filopodia rotate and coil by actively generating twist in their actin shaft
por: Leijnse, Natascha, et al.
Publicado: (2022)

BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target
por: Bezrookove, Vladimir, et al.
Publicado: (2022)

Transcription Factors as Novel Therapeutic Targets and Drivers of Prostate Cancer Progression
por: Xie, Kangzhe, et al.
Publicado: (2022)

TAM-targeted reeducation for enhanced cancer immunotherapy: Mechanism and recent progress
por: Shen, Xinyuan, et al.
Publicado: (2022)

Interview with the ECM Award winner 2022 and introducing the new ECM members
por: Son, Kiho, et al.
Publicado: (2023)

Disruption of Prostate Epithelial Differentiation Pathways and Prostate Cancer Development
por: Frank, Sander B., et al.
Publicado: (2013)

Endocrine-disrupting chemicals and breast cancer: a meta-analysis
por: Liu, Haiyan, et al.
Publicado: (2023)

METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway
por: Yang, Dong-Dong, et al.
Publicado: (2020)

Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer
por: Xu, Donghan, et al.
Publicado: (2023)

ECM communicates with MMP
por: LeBrasseur, Nicole
Publicado: (2002)

ECM determines fate
por: Leslie, Mitch
Publicado: (2006)

The ECM Moves during Primitive Streak Formation—Computation of ECM Versus Cellular Motion
por: Zamir, Evan A, et al.
Publicado: (2008)

Racial and Ethnic Differences in the Financial Consequences of Cancer-Related Employment Disruption
por: Biddell, Caitlin B., et al.
Publicado: (2021)

MicroRNA-99a Suppresses Breast Cancer Progression by Targeting FGFR3
por: Long, Xinghua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gt3ggq3g3r6ovi95ov6i0hefof